Study population
SECONDARY, COLD
The population used for efficacy analyses was a MITT population including all randomized patients who received a transplant. This was a change from the original protocol because it was deemed illogical to include those participants who did not receive a transplant, as no outcome data were available. Primary and secondary outcomes were also analyzed per protocol, which excluded any participant who did not receive a transplant, was randomized in error, experienced a protocol deviation or was withdrawn from the trial (details are provided in the statistical analysis plan). For both analysis populations, results were presented by randomized treatment, and all ratios and mean differences were presented as NMP versus SCS.All analyses were adjusted for cold ischemic time, donor age, left/right kidney and transplant center (all as fixed effects). All tests were two-sided, and 